furosemide has been researched along with Liver Dysfunction in 54 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combined use of furosemide with albumin is an approved therapy to overcome diuretic resistance in treatment of ascites in decompensated chronic liver disease." | 9.34 | Comparative Study of Slow Infusion versus Bolus Doses of Albumin and Furosemide Infusion to Mobilize Refractory Ascites in Decompensated Chronic Liver Disease. ( Jha, A; Kafle, B; Khadga, P; Pathak, R; Thapaliya, S; Yadav, AK, 2020) |
| "Among 459 patients with hepatic edema enrolled in a retrospective, multicenter collaborative study, we analyzed 407 patients who received tolvaptan." | 7.96 | Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. ( Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y, 2020) |
| " We present the case of a patient with hypoxic hepatitis in the setting of heart failure and dehydration from furosemide as a reminder of an important clinical lesson." | 7.88 | Hypoxic hepatitis and furosemide. ( Pizzarossa, AC; Rebella, M, 2018) |
| "Furosemide occasionally causes azotemia in patients with ascites, independently of induced volume depletion." | 7.67 | Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. ( Daskalopoulos, G; Harley, H; Laffi, G; Morgan, T; Pinzani, M; Reynolds, T; Zipser, RD, 1987) |
| "Combined use of furosemide with albumin is an approved therapy to overcome diuretic resistance in treatment of ascites in decompensated chronic liver disease." | 5.34 | Comparative Study of Slow Infusion versus Bolus Doses of Albumin and Furosemide Infusion to Mobilize Refractory Ascites in Decompensated Chronic Liver Disease. ( Jha, A; Kafle, B; Khadga, P; Pathak, R; Thapaliya, S; Yadav, AK, 2020) |
| "Furosemide (frusemide) is a potent loop diuretic used in the treatment of oedematous states associated with cardiac, renal and hepatic failure, and for the treatment of hypertension." | 4.78 | Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I). ( Ponto, LL; Schoenwald, RD, 1990) |
| " Some examples such as the modification of furosemide pharmacokinetics in acute renal failure, the impaired metabolism of opiate analgesics in hepatic insufficiency, the alterations of the usual disposition process in salicylic acid intoxication, and the influence of cardiac failure upon some drugs pharmacokinetics, have been chosen to illustrate some of the aspects discussed." | 4.76 | Disease-induced modifications of drug pharmacokinetics. ( Barre, J; Bree, F; Brunner, F; Houin, G; Tillement, JP, 1983) |
| "Among 459 patients with hepatic edema enrolled in a retrospective, multicenter collaborative study, we analyzed 407 patients who received tolvaptan." | 3.96 | Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema. ( Abe, H; Arai, T; Atsukawa, M; Chuma, M; Fukunishi, S; Hattori, N; Hiraoka, A; Iio, E; Ikegami, T; Itokawa, N; Iwakiri, K; Iwasa, M; Kato, K; Kondo, C; Kumada, T; Michitaka, K; Nakagawa-Iwashita, A; Nozaki, A; Okubo, H; Okubo, T; Senoh, T; Tada, T; Takaguchi, K; Takei, Y; Tanaka, Y; Tani, J; Toyoda, H; Tsubota, A; Tsutsui, A; Uojima, H; Watanabe, T; Yokohama, K; Yoshida, Y, 2020) |
| " We present the case of a patient with hypoxic hepatitis in the setting of heart failure and dehydration from furosemide as a reminder of an important clinical lesson." | 3.88 | Hypoxic hepatitis and furosemide. ( Pizzarossa, AC; Rebella, M, 2018) |
| " Kinetic parameters were determined in plasma and urine; further, in patients with liver cirrhosis, renal elimination kinetics of the diuretic were correlated with the concentration of direct plasma bilirubin, as a marker of cholestasis, at the beginning of a treatment with xipamide, 40 mg qd." | 3.73 | [Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients]. ( Knauf, H; Mutschler, E, 2005) |
| "Furosemide occasionally causes azotemia in patients with ascites, independently of induced volume depletion." | 3.67 | Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. ( Daskalopoulos, G; Harley, H; Laffi, G; Morgan, T; Pinzani, M; Reynolds, T; Zipser, RD, 1987) |
| "Furosemide-induced (400mg/kg ip) hepatotoxicity progressing to centrilobular necrosis was studied by light and electron microscopy in Swiss white mice." | 3.66 | Furosemide induced hepatotoxicity. ( McElligott, TF; Walker, RM, 1981) |
| "The binding of three loop diuretics, piretanide, bumetanide and furosemide, to serum proteins from patients with liver cirrhosis or fulminant hepatitis was investigated using equilibrium dialysis." | 3.66 | Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease. ( Fujii, S; Fujiwara, K; Goto, S; Miyamoto, A; Nakayama, T; Yamada, H; Yoshitomi, H, 1981) |
| "Five patients with hepatorenal syndrome were treated with a LeVeen peritoneovenous shunt and furosemide." | 3.66 | Treatment of hepatorenal syndrome. ( Schwartz, ML; Vogel, SB, 1980) |
| "Drug-induced hepatic encephalopathy was more common in cirrhotics receiving diuretics (13." | 1.27 | An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease. ( Busto, U; Janecek, E; Kaplan, K; Naranjo, CA; Roach, CA; Ruiz, I, 1983) |
| " The dosage of furosemide did not account for the increased frequency of ARs in patients with hepatic disease." | 1.26 | Furosemide-induced adverse reactions during hospitalization. ( Busto, U; Cassis, L; Naranjo, CA, 1978) |
| "Phenformin treatment should be avoided in case of renal and/or liver insufficiency." | 1.25 | Phenformin-induced lactic acidosis in diabetic patients. ( Assan, R; Attali, JR; Girard, JR; Heuclin, C; LeMaire, F, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 44 (81.48) | 18.7374 |
| 1990's | 2 (3.70) | 18.2507 |
| 2000's | 4 (7.41) | 29.6817 |
| 2010's | 2 (3.70) | 24.3611 |
| 2020's | 2 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Atsukawa, M | 1 |
| Tsubota, A | 1 |
| Takaguchi, K | 1 |
| Toyoda, H | 1 |
| Iwasa, M | 1 |
| Ikegami, T | 1 |
| Chuma, M | 1 |
| Nozaki, A | 1 |
| Uojima, H | 1 |
| Hiraoka, A | 1 |
| Fukunishi, S | 1 |
| Yokohama, K | 1 |
| Tada, T | 1 |
| Kato, K | 1 |
| Abe, H | 1 |
| Tani, J | 1 |
| Okubo, H | 1 |
| Watanabe, T | 1 |
| Hattori, N | 1 |
| Tsutsui, A | 1 |
| Senoh, T | 1 |
| Yoshida, Y | 1 |
| Okubo, T | 1 |
| Itokawa, N | 1 |
| Nakagawa-Iwashita, A | 1 |
| Kondo, C | 1 |
| Arai, T | 1 |
| Michitaka, K | 1 |
| Iio, E | 1 |
| Kumada, T | 1 |
| Tanaka, Y | 1 |
| Takei, Y | 1 |
| Iwakiri, K | 1 |
| Pathak, R | 1 |
| Yadav, AK | 1 |
| Thapaliya, S | 1 |
| Kafle, B | 1 |
| Jha, A | 1 |
| Khadga, P | 1 |
| Pizzarossa, AC | 1 |
| Rebella, M | 1 |
| Eshar, D | 1 |
| Peddle, GD | 1 |
| Briscoe, JA | 1 |
| CANTERINANTONINI, S | 1 |
| CANTERINANTONINI, A | 1 |
| PAGANO, G | 1 |
| PISANO, E | 1 |
| PELLEGRINI, A | 1 |
| Knauf, H | 1 |
| Mutschler, E | 1 |
| Kobayashi, C | 1 |
| Sasaki, H | 1 |
| Kosuge, K | 1 |
| Miyakita, Y | 1 |
| Hayakawa, M | 1 |
| Suzuki, A | 1 |
| Abe, E | 1 |
| Suzuki, K | 1 |
| Aizawa, Y | 1 |
| Di Costanzo, GG | 1 |
| Ragozzino, A | 1 |
| Niola, R | 1 |
| Maglione, F | 1 |
| Ascione, A | 1 |
| Arai, A | 1 |
| Yan, W | 1 |
| Wakabayashi, S | 1 |
| Hayashi, S | 1 |
| Inazawa, J | 1 |
| Miura, O | 1 |
| Pupita, F | 2 |
| Bartoli, E | 1 |
| Molaschi, M | 1 |
| Schnitzler, R | 1 |
| Fritz, KW | 1 |
| Barre, J | 1 |
| Houin, G | 1 |
| Brunner, F | 1 |
| Bree, F | 1 |
| Tillement, JP | 1 |
| Naranjo, CA | 2 |
| Busto, U | 2 |
| Janecek, E | 1 |
| Ruiz, I | 1 |
| Roach, CA | 1 |
| Kaplan, K | 1 |
| Goto, S | 2 |
| Yoshitomi, H | 2 |
| Miyamoto, A | 2 |
| Inoue, K | 1 |
| Nakano, M | 1 |
| Walker, RM | 1 |
| McElligott, TF | 1 |
| Yamada, H | 1 |
| Fujii, S | 1 |
| Nakayama, T | 1 |
| Fujiwara, K | 1 |
| Schwartz, ML | 1 |
| Vogel, SB | 1 |
| García Puig, J | 1 |
| Mateos Anton, F | 1 |
| Anciones, B | 1 |
| Grande, C | 1 |
| Gilaquado, A | 1 |
| Arnalich, F | 1 |
| Barbado, J | 1 |
| Vázquez, JJ | 1 |
| Gisbert, P | 1 |
| Martin, P | 1 |
| Casares, M | 1 |
| Riñón, M | 1 |
| Ortíz Vázquez, J | 1 |
| Montero García, A | 1 |
| Jolobe, OM | 1 |
| Epstien, M | 1 |
| Blendis, LM | 1 |
| Greig, PD | 1 |
| Langer, B | 1 |
| Baigrie, RS | 1 |
| Ruse, J | 1 |
| Taylor, BR | 1 |
| Dreux, C | 1 |
| Passa, P | 1 |
| Halter, D | 1 |
| McMurtry, RJ | 1 |
| Mitchell, JR | 2 |
| Cassis, L | 1 |
| Borirakchanyavat, V | 1 |
| Sitprija, V | 1 |
| Luke, RG | 1 |
| Assan, R | 1 |
| Heuclin, C | 1 |
| Girard, JR | 1 |
| LeMaire, F | 1 |
| Attali, JR | 1 |
| Spitznagle, LA | 1 |
| Wirth, PJ | 1 |
| Boobis, SW | 1 |
| Thorgeirsson, SS | 1 |
| Nelson, WL | 1 |
| Thiele, KG | 1 |
| Wilmink, JM | 1 |
| Snodgrass, WR | 1 |
| Gillette, JR | 1 |
| Danks, DM | 1 |
| Ponto, LL | 1 |
| Schoenwald, RD | 1 |
| Viani, A | 1 |
| Carrai, M | 1 |
| Pacifici, GM | 1 |
| Huang, Y | 1 |
| Kamiya, A | 1 |
| Hayashi, Y | 1 |
| Inui, K | 1 |
| Hori, R | 1 |
| Daskalopoulos, G | 1 |
| Laffi, G | 1 |
| Morgan, T | 1 |
| Pinzani, M | 1 |
| Harley, H | 1 |
| Reynolds, T | 1 |
| Zipser, RD | 1 |
| Pockros, PJ | 1 |
| Reynolds, TB | 1 |
| Campolucci, G | 1 |
| Pulido, M | 1 |
| Belogi, M | 1 |
| Rotatori, P | 1 |
| Ansuini, R | 1 |
| Frausini, G | 1 |
| Barone, A | 1 |
| Gaggi, S | 1 |
| Siciński, A | 1 |
| Horrobin, DF | 1 |
| Manku, MS | 1 |
| Nassar, BA | 1 |
| Dzúriková, V | 1 |
| Brixová, E | 1 |
| Niederland, TR | 1 |
| Reubi, FC | 1 |
| Klebanoff, G | 1 |
| Hollander, D | 1 |
| Cosimi, AB | 1 |
| Stanford, W | 1 |
| Kemmerer, WT | 1 |
| Szende, L | 1 |
| Radó, J | 1 |
| Takó, J | 1 |
| Cohn, JN | 1 |
| Tristani, FE | 1 |
| Khatri, IM | 1 |
| Szám, I | 1 |
| Gläsel, E | 1 |
| Gentili, G | 1 |
| Liberti, R | 1 |
| Klütsch, K | 1 |
| Pickert, H | 1 |
| Müller, K | 1 |
| Henning, H | 1 |
| Steigmann, F | 1 |
| Oz, R | 1 |
| Dubin, A | 1 |
| Terrasse, J | 1 |
| Derycke, C | 1 |
| Marcheix, JC | 1 |
| Kuzmanic, A | 1 |
| Faivovich, A | 1 |
| Del Rio, R | 1 |
| Jaruffe, F | 1 |
| Vera, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Bioequivalence Study of Furosemide in Indonesian Healthy Volunteers[NCT04982874] | 24 participants (Actual) | Interventional | 2019-12-13 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The ratio between test drug and reference drug (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | percentage (Geometric Mean) |
|---|---|
| Furosemide 40 mg Tablet | 101.79 |
The ratio between test drug and reference drug (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | percentage (Geometric Mean) |
|---|---|
| Furosemide 40 mg Tablet | 104.51 |
Area Under Curve from 0 to 24 hours (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | ng*h/mL (Mean) |
|---|---|
| Furosemide 40 mg Tablet | 4938.79 |
| Lasix® 40 mg Tablet | 4921.94 |
Maximum plasma concentration (NCT04982874)
Timeframe: before dosing (0 h) and at 0.25, 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 8, 10, 12, 16 and 24 hours after drug administration
| Intervention | ng/mL (Mean) |
|---|---|
| Furosemide 40 mg Tablet | 1893.09 |
| Lasix® 40 mg Tablet | 1907.32 |
7 reviews available for furosemide and Liver Dysfunction
| Article | Year |
|---|---|
Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity.
Topics: Adult; Antineoplastic Agents; Benzamides; Biopsy; Chemical and Drug Induced Liver Injury; Chromosome | 2007 |
Disease-induced modifications of drug pharmacokinetics.
Topics: Acute Kidney Injury; Blood Proteins; Disease; Furosemide; Glomerular Filtration Rate; Heart Failure; | 1983 |
Deranged renal function in liver disease.
Topics: Angiotensin II; Diet, Sodium-Restricted; Furosemide; Humans; Hyperaldosteronism; Kidney; Kidney Dise | 1977 |
Diagnostic possibilities in acute renal failure.
Topics: Acute Kidney Injury; Blood Circulation; Blood Urea Nitrogen; Blood Volume; Extracellular Space; Furo | 1976 |
Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part I).
Topics: Acute Kidney Injury; Furosemide; Heart Failure; Humans; Hypertension; Liver Diseases | 1990 |
[Advances in nephrology. Chronic renal failure].
Topics: Bone and Bones; Cataract; Deafness; Female; Furosemide; Gastrointestinal Diseases; Humans; Hypercalc | 1974 |
Combination diuretic drug therapy.
Topics: Amiloride; Benzothiadiazines; Diet; Diuretics; Drug Therapy, Combination; Ethacrynic Acid; Furosemid | 1971 |
1 trial available for furosemide and Liver Dysfunction
| Article | Year |
|---|---|
Comparative Study of Slow Infusion versus Bolus Doses of Albumin and Furosemide Infusion to Mobilize Refractory Ascites in Decompensated Chronic Liver Disease.
Topics: Albumins; Ascites; Furosemide; Humans; Infusions, Intravenous; Liver Diseases; Nepal | 2020 |
46 other studies available for furosemide and Liver Dysfunction
| Article | Year |
|---|---|
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edema.
Topics: Adult; Aged; Aged, 80 and over; Diuretics; Drug Therapy, Combination; Edema; Female; Furosemide; Hum | 2020 |
Hypoxic hepatitis and furosemide.
Topics: Chemical and Drug Induced Liver Injury; Dehydration; Diagnosis, Differential; Diuretics; Echocardiog | 2018 |
Diagnosis and treatment of congestive heart failure secondary to hypertrophic cardiomyopathy in a kinkajou (Potos flavus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Infective Agents; Cardiomyopathy, Hypertroph | 2010 |
[FIRST EXPERIENCES WITH A NEW DIURETIC: FUROSEMIDE].
Topics: Diuretics; Furosemide; Heart Diseases; Humans; Liver Diseases | 1965 |
[CLINICAL EXPERIENCES WITH A NEW SYNTHETIC DIURETIC: FUROSEMIDE].
Topics: Diuretics; Furosemide; Heart Diseases; Hypertension; Liver Diseases | 1965 |
[Mechanism of action of xipamide and its classification as a "low ceiling diuretic". Pharmacodynamic-pharmacokinetic studies in healthy volunteers and in kidney and liver patients].
Topics: Bilirubin; Cholestasis; Creatinine; Diet, Sodium-Restricted; Diuresis; Diuretics; Furosemide; Glomer | 2005 |
Severe starvation hypoglycemia and congestive heart failure induced by thyroid crisis, with accidentally induced severe liver dysfunction and disseminated intravascular coagulation.
Topics: Aged; Blood Glucose; Blood Pressure; Chemical and Drug Induced Liver Injury; Disseminated Intravascu | 2005 |
A rare cause of diuretic refractory ascites.
Topics: Ascites; Constriction, Pathologic; Cysts; Diuretics; Female; Furosemide; Humans; Liver Diseases; Mag | 2006 |
[Recent advances in the physiopathology and therapy of edematogenic states].
Topics: Adrenal Cortex Hormones; Adult; Digitalis Glycosides; Diuretics; Edema; Female; Furosemide; Heart Fa | 1966 |
[A comparative clinical investigation of the diuretic furosemide].
Topics: Acute Kidney Injury; Benzothiadiazines; Chlorides; Diuretics; Eclampsia; Edema; Female; Furosemide; | 1966 |
An intensive drug monitoring study suggesting possible clinical irrelevance of impaired drug disposition in liver disease.
Topics: Brain Diseases; Diuretics; Drug Evaluation; Drug-Related Side Effects and Adverse Reactions; Furosem | 1983 |
Binding of several loop diuretics to serum albumin and human serum from patients with renal failure and liver disease.
Topics: Adult; Animals; Blood Proteins; Bumetanide; Cattle; Diuretics; Female; Furosemide; Humans; Kidney Fa | 1980 |
Furosemide induced hepatotoxicity.
Topics: Animals; Chemical and Drug Induced Liver Injury; Erythrocytes; Furosemide; Liver; Liver Diseases; Ma | 1981 |
Further investigations on the binding of loop diuretics to serum proteins from patients with liver disease.
Topics: Adult; Bilirubin; Blood Proteins; Bumetanide; Diuretics; Female; Furosemide; Hepatitis; Humans; Live | 1981 |
Treatment of hepatorenal syndrome.
Topics: Adult; Ascites; Ascitic Fluid; Creatine; Furosemide; Humans; Infusions, Parenteral; Kidney Diseases; | 1980 |
[Influence of furosemide on the acidifying dysfunction of renal tubular acidosis].
Topics: Acidosis, Renal Tubular; Chronic Disease; Diuresis; Furosemide; Humans; Hydrogen-Ion Concentration; | 1980 |
Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis.
Topics: Aged; Captopril; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Furo | 1993 |
The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Topics: Adult; Aged; Aldosterone; Ascites; Body Weight; Budd-Chiari Syndrome; Cardiac Output; Diuresis; Drai | 1979 |
Influence of hepatic insufficiency in pharmacokinetics of drugs: example for an anthranilic diuretic.
Topics: Adult; Aged; Furosemide; Humans; Kinetics; Liver Cirrhosis; Liver Diseases; Middle Aged; Pharmaceuti | 1979 |
Renal and hepatic necrosis after metabolic activation of 2-substituted furans and thiophenes, including furosemide and cephaloridine.
Topics: Animals; Cephaloridine; Chemical and Drug Induced Liver Injury; Furans; Furosemide; In Vitro Techniq | 1977 |
Furosemide-induced adverse reactions during hospitalization.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Child; Chile; Dose-Response Relationship, Drug; Dr | 1978 |
Frusemide in liver diseases with renal failure.
Topics: Acute Kidney Injury; Adult; Aged; Furosemide; Hepatitis A; Humans; Liver Cirrhosis; Liver Diseases; | 1978 |
Phenformin-induced lactic acidosis in diabetic patients.
Topics: Adult; Aged; Bicarbonates; Blood Glucose; Carbon Dioxide; Diabetes Mellitus; Diabetic Ketoacidosis; | 1975 |
The role of biliary excretion in the hepatotoxicity of furosemide in the mouse.
Topics: Animals; Autoradiography; Bile; Blood Proteins; Chemical and Drug Induced Liver Injury; Furosemide; | 1977 |
[Renal disorders in hepatic insufficiency - pathogenesis and therapy (author's transl)].
Topics: Acute Kidney Injury; Blood Volume; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Kidney Tu | 1977 |
Some clinical aspects of acute renal failure.
Topics: Acute Kidney Injury; Anuria; Furosemide; Glomerulonephritis; Humans; Liver Diseases; Mannitol; Nephr | 1977 |
The role of biotransformation in chemical-induced liver injury.
Topics: Acetaminophen; Animals; Biotransformation; Bromobenzenes; Chemical and Drug Induced Liver Injury; Cr | 1976 |
Letter: Diuretic therapy in infants and children.
Topics: Child; Furosemide; Humans; Infant; Liver Diseases; Spironolactone | 1976 |
Plasma protein binding of frusemide in liver disease: effect of hypoalbuminaemia and hyperbilirubinaemia.
Topics: Adult; Aged; Blood Proteins; Dialysis; Female; Furosemide; Humans; Hyperbilirubinemia; Liver Disease | 1989 |
Decreased diuretic response to furosemide in rats with acute hepatic failure.
Topics: Adrenalectomy; Aldosterone; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; D | 1988 |
Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites.
Topics: Ascites; Blood Pressure; Chronic Disease; Furosemide; Hemodynamics; Humans; Inulin; Kidney; Liver Di | 1987 |
Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.
Topics: Amiloride; Ascites; Body Weight; Chronic Disease; Diuresis; Edema; Electrolytes; Furosemide; Humans; | 1986 |
[Indications for therapy with diuretics].
Topics: Aldosterone; Blood Volume; Cardiac Output; Diuretics; Edema; Edema, Cardiac; Furosemide; Humans; Kid | 1985 |
Letter: Hepatorenal syndrome and prolactin.
Topics: Animals; Furosemide; Humans; Kidney Diseases; Liver Diseases; Prolactin; Rats; Syndrome | 1974 |
[Effect of single administration of furosemide in patients with chronic liver disease].
Topics: Chronic Disease; Furosemide; Humans; Hyperglycemia; Liver Diseases | 1974 |
Asanguineous hypothermic total body perfusion (TBW) in the treatment of stage IV hepatic coma.
Topics: Autopsy; Biopsy; Blood Chemical Analysis; Blood Gas Analysis; Blood Pressure Determination; Blood Tr | 1972 |
[Clinico-pharmacological studies of furosemide].
Topics: Furosemide; Glomerular Filtration Rate; Heart Diseases; Humans; Kidney Diseases; Liver Diseases; Nat | 1971 |
Renal vasodilator therapy in the hepatorenal syndrome.
Topics: Furosemide; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Vasodilator Agents | 1970 |
[Prevention and therapy of hepatic coma].
Topics: Aged; Amides; Ammonia; Aspartic Acid; Chlorothiazide; Clopamide; Depression, Chemical; Diuretics; Fe | 1970 |
[Clinical aspect and therapy of a severe acute dinitroorthocresol poisoning].
Topics: Acidosis; Adenosine Triphosphate; Adult; Bicarbonates; Bloodletting; Brain Edema; Carbohydrates; Cre | 1970 |
[Clinical study of the use of "Spirolang" 50].
Topics: Adult; Aged; Ascites; Chronic Disease; Digitalis Glycosides; Diuresis; Electrolytes; Ethacrynic Acid | 1971 |
[Treatment of the so-called hepatorenal syndrome].
Topics: Acute Kidney Injury; Anti-Bacterial Agents; Diet, Sodium-Restricted; Dietary Carbohydrates; Dietary | 1968 |
[The effect of furosemide on the liver function].
Topics: Adult; Aged; Female; Furosemide; Hepatitis; Humans; Liver Cirrhosis; Liver Diseases; Liver Function | 1966 |
Newer diuretics in the treatment of cardiac or hepatic disease in elderly patients.
Topics: Ascites; Benzothiadiazines; Blood Glucose; Blood Urea Nitrogen; Body Weight; Cardiovascular Diseases | 1966 |
[Study of a diuretic, furosemide, in hospital practice].
Topics: Edema; Furosemide; Heart Diseases; Humans; Liver Diseases; Obesity | 1966 |
[Experience with a new diuretic Furosemide].
Topics: Edema; Furosemide; Heart Failure; Humans; Kidney Diseases; Liver Diseases | 1966 |